Featured Research

from universities, journals, and other organizations

Jefferson Scientists Hope To Perfect Gene Therapy Without Viruses

Date:
August 28, 2000
Source:
Jefferson Medical College
Summary:
Gene therapy – which aims to replace "bad" genes with useful ones – has yet to live up to its promise largely because of problems delivering genes to the right place in the body. What’s more, the viruses many gene therapy techniques use can arouse unwanted immune reactions. Researchers at Jefferson Medical College have developed a system that sidesteps viruses, and they hope, some of the inherent problems with their use.

Gene therapy – which aims to replace "bad" genes with useful ones – has yet to live up to its promise largely because of problems delivering genes to the right place in the body. What’s more, the viruses many gene therapy techniques use can arouse unwanted immune reactions.

Researchers at Jefferson Medical College have developed a system that sidesteps viruses, and they hope, some of the inherent problems with their use. Scientists, led by Eric Wickstrom, PhD, professor of microbiology and immunology, and graduate research assistant Stephen H. Cleaver, both of Jefferson Medical College and Thomas Jefferson University in Philadelphia, have used DNA and bacterial proteins to deliver a gene to a specific place in a piece of human DNA.

They have used a "transposon," or a naturally mobile piece of DNA, from the E. coli bacterium as a gene delivery vehicle, inserting a gene for antibiotic resistance into a segment of DNA.

"This is the first time it [gene therapy] was done this way," says Dr. Wickstrom, who is also a member of Jefferson’s Kimmel Cancer Center. Their results appear August 22 in the journal Gene.

"The transposon inserted in exactly the right place and expressed its product, in this case, an antibiotic-resistant gene." The technique has several advantages, he says. "It avoids using viruses that cause immune reactions, it puts the gene in a precise, known location as opposed to anywhere in the cell’s DNA, and it makes only one copy."

There are significant problems with viral methods, Dr. Wickstrom says. In traditional gene therapy methods, there is a question of how many gene copies may be made in each individual and where in the cell’s DNA a copy may go. "The genes could go anywhere in the genome. This may be okay, or they could interact inappropriately with other genes, such as a tumor suppressor gene, knocking out its function and starting a cancer."

Dr. Wickstrom points out that his current tests so far have been only in bacteria to date. "We would like to avoid these problems and still have an effective method," he explains. "We’ve only done this in bacteria – not a higher organism, though this was with a human genomic sequence."

The Jefferson team was awarded a patent for the technique and a new grant for more than $660,000 from the National Institutes of Health to continue to develop their method of gene transfer in yeast and mice.

Dr. Wickstrom notes that gene therapy with and without viruses currently is being studied in clinical trials by many researchers in this country and overseas. In his recent book, "Clinical Trials of Genetic Therapy with Antisense DNA and DNA Vectors," he and his co-authors described a variety of preclinical and clinical studies in the United States and other countries.

He adds "the ability to turn off or correct individual disease-causing genes, or to replace them at will in a patient’s cells provides a powerful therapeutic intervention in genetic diseases.

"It’s clear that all disease results from incorrect gene expression, one way or another," he notes. "By turning off some genes or correcting others, we may be able to treat each disease at its point of origin." Eventually, Dr. Wickstrom hopes to use his nonviral method to provide normally functioning genes in diseases such as hemophilia, sickle cell anemia, muscular dystrophy, and phenylketonuria, and therapeutic genes to treat cancer.


Story Source:

The above story is based on materials provided by Jefferson Medical College. Note: Materials may be edited for content and length.


Cite This Page:

Jefferson Medical College. "Jefferson Scientists Hope To Perfect Gene Therapy Without Viruses." ScienceDaily. ScienceDaily, 28 August 2000. <www.sciencedaily.com/releases/2000/08/000823082148.htm>.
Jefferson Medical College. (2000, August 28). Jefferson Scientists Hope To Perfect Gene Therapy Without Viruses. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2000/08/000823082148.htm
Jefferson Medical College. "Jefferson Scientists Hope To Perfect Gene Therapy Without Viruses." ScienceDaily. www.sciencedaily.com/releases/2000/08/000823082148.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins